These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11188854)

  • 1. [Collagenase production increases in rheumatoid arthritis and osteoarthritis synoviocytes incubated].
    Montrull HL; Brizuela NY; Demurtas SL; Strusberg AM; Spitale LS; Meirovich CI
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(1):51-7. PubMed ID: 11188854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis.
    Clark IM; Powell LK; Ramsey S; Hazleman BL; Cawston TE
    Arthritis Rheum; 1993 Mar; 36(3):372-9. PubMed ID: 8452582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes.
    Alquraini A; Jamal M; Zhang L; Schmidt T; Jay GD; Elsaid KA
    Arthritis Res Ther; 2017 May; 19(1):89. PubMed ID: 28482921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10.
    Tolboom TC; Pieterman E; van der Laan WH; Toes RE; Huidekoper AL; Nelissen RG; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2002 Nov; 61(11):975-80. PubMed ID: 12379519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators.
    Choi HM; Lee YA; Lee SH; Hong SJ; Hahm DH; Choi SY; Yang HI; Yoo MC; Kim KS
    Arthritis Res Ther; 2009; 11(6):R161. PubMed ID: 19883500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
    Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
    Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
    Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
    Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis].
    Itoh T; Uzuki M; Shimamura T; Sawai T
    Ryumachi; 2002 Feb; 42(1):60-9. PubMed ID: 11925908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Nakano S; Ikata T; Kinoshita I; Kanematsu J; Yasuoka S
    Clin Exp Rheumatol; 1999; 17(2):161-70. PubMed ID: 10342041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.